Why Insulin in Type 2 DM?

Why is Insulin used in Type 2 Diabetes Mellitus?

Let's begin with the basics on how Insulin works:

https://s.hswstatic.com/gif/diabetes-glucose-regulation.gif
TYPES OF DIABETES MELLITUS
TYPE 1 DIABETES MELLITUS
TYPE 2 DIABETES MELLITUS


Commonly 2nd and 3rd decades of life
Commonly 6th and 7th decades of life
Caused by autoimmune destruction of pancreatic beta cells
Caused by insulin resistance at peripheral adipose and muscle tissues
Insulin levels- Decreased
Insulin levels- increased

Based on the common differences between the two entities, it would seem that the mainstay of treatment for Type 1 DM is insulin (which it is) and that for Type 2 DM would be anything other than insulin ( given the already elevated insulin levels).
Conventional treatment of Type II Diabetes Mellitus starts with:

 1.Lifestyle modifications - Exercise, eating healthy, decreased consumption of alcohol and tobacco.

 2.Oral hypoglycemics – some of which decrease insulin resistance and some of which increase pancreatic secretion of insulin.

 3.Insulin
Now answering your specific question:
Why is Insulin used in Type 2 Diabetes Mellitus?
This can also be paraphrased to – why are oral hypoglycemics such as sulfonylureas (which increase pancreatic secretion of insulin), used in Type 2 DM, given that there’s already increased insulin levels within the body??
The answer to this question is not simple but stems from research-hypothesized theories of the pathophysiology of Type 2 DM.
The pathophysiology of type 2 DM is more complex than it appears. Multiple studies done on Pima Indians[1] [2] (a group of Native Americans living in an area consisting of what is now central and southern Arizona, known to be the most genetically predisposed race to Type 2 Diabetes Mellitus) , illustrate the complex pathophysiology of Type 2 DM. The entire spectrum of pathophysiology appears to be based of the image given below.
As is evident from the diagram, the pathophysiology of Type 2 DM in its it's most severe stage involves a failure of beta- pancreatic cells which causes a net insulin deficit in the body, (this stage was prevalent in Pima Indians.) Thus arises the need for insulin and insulin secreting hypoglycemics in type 2 DM
Image result for paTHOPHYSIOLOGY OF dm TYPE 2
By Dr Jason D'Cruz
References:

1)Weyer C, Bogardus C, Mott DM, Pratley RE
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104:787–794pmid:10491414
Baier LJ, Hanson RL


2)Genetic studies of the etiology of type 2 diabetes in Pima Indians: hunting for pieces to a complicated puzzle. Diabetes 2004; 53:1181–1186pmid:15111484

Comments

Post a Comment

Popular posts from this blog

The Icebreaker: Contraction Alkalosis

Image
The Icebreaker: What is Contraction alkalosis ?? The word 'contraction' in contraction alkalosis refers to fluid contraction or in other words, fluid loss . So when the body loses fluid (typically seen with diuretics) it tries to get all that fluid back. Q: How can the body do this ?   A: By increasing the serum sodium concentration. (increased sodium concentration --> increased osmolarity of serum --> increase in intravascular volume) Q: How does the body do it ? A:1) The decreased blood volume is sensed as decreased blood pressure felt by the kidneys at the glomerulus ie. decreased renal perfusion pressure. There are modified smooth muscle cells in the afferent arteriole that detect this change called JG cells . They secrete Renin in response to the low pressures.  2) By the diagram shown below Renin activates an axis that gives rise to Angiotensin II and aldosterone.   The Renin-Angiotensin-Aldosterone axis   3) Angiotens
Read more

Dexametha-Zone

Image
Q: What is the importance of Low Dose and High Dose Dexamethasone Suppression Tests? A: Let's begin with the HPA (Hypothalamus-Pituitary-Adrenal) axis: Cortisol suppresses the release of both CRH from the hypothalamus as well as ACTH from the pituitary. Low Dose Dexamethasone Test: The Overnight DST which is a type of Low Dose DST is used to rule out a hypercortisolism state or the diagnosis of Cushing’s syndrome. It is based on the principle that in a normal individual a low dose of dexamethasone is sufficient to suppress the ACTH production and hence the cortisol levels. Procedure: Overnight Dexamethasone test : 1 mg of Dexamethasone is given at 11pm and the cortisol level is measured at 8am. Failure to suppress the cortisol level to less than 50 nmol/L signifies Cushing's syndrome. LDDST : 0.5mg Dexamethasone q6h for 2 days and then the plasma cortisol is measured. Plasma cortisol more than 50 nmol/L is considered abnormal. Any abnormalit
Read more

Are SGLT2 inhibitors renoprotective?

Image
SGLT2 Inhibitors and Renoprotection Q: “How do SGLT2 inhibitors help in chronic kidney disease?” A: The renoprotective effect of SGLT2 inhibitors is still being extensively studied, but the results have been very promising. Let’s start with discussing what SGLT2 inhibitors are. SGLT 2 inhibitors SGLT2 inhibitors (eg dapagliflozin, canagliflozin, empagliflozin etc) are a class of drugs that inhibit reabsorption of glucose in the kidney (by inhibiting the sodium-glucose transport protein 2 - ie, SGLT2) and therefore lower blood sugar. Because of their use in lowering blood glucose levels, they are regularly used in the management of type 2 diabetes mellitus (and increasingly in type 1 diabetes as well). In addition to glycemic control, they have been shown to provide significant cardiovascular benefit in patients with type 2 diabetes. Mechanism Sodium Glucose cotransporters (SGLTs) are proteins that are found in different tissues that play an important role in mai
Read more